Coronavirus disease 2019 (COVID-19) and immune-mediated rheumatic diseases. Recommendations of the association of rheumatologists of Russia
E. L. Nasonov,A. M. Lila,Vadim I. Mazurov,B. S. Belov,A. E. Karateev,Tatiana Dubinina,O. A. Nikitinskaya,A. A. Baranov,Diana Abdulganieva,S. V. Moiseev,A. I. Zagrebneva +10 more
- Vol. 59, Iss: 3, pp 239-254
Reads0
Chats0
TLDR
The new version of the recommendations of the Association of Rheumatologists of Russia formulates the main provisions concerning the tactics of managing patients with Immune-mediated Rheumatic Diseases during the ongoing COVID-19 pandemic.Citations
More filters
Journal ArticleDOI
Деплеция в-клеток при иммуновоспалительных ревматических заболеваниях и коронавирусная болезнь 2019 (covid-19)
Е. Л. Насонов,А. С. Авдеева +1 more
TL;DR: According to the recommendations of the Association of Rheumatologists of Russia, a more rigorous assessment of indications for induction and maintenance therapy of RTX therapy and harmonization of the timing of drug administration and vaccination is required.
Journal ArticleDOI
Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
TL;DR: The frequency of exacerbation of RD after vaccination against COVID-19 seems to be quite low (5–7%) and has no significant associations with a specific vaccine or anti-rheumatic therapy, and unambiguous interpretation is difficult.
Journal ArticleDOI
Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology
Evgeny Nasonov,T.V. Korotaeva +1 more
TL;DR: The current achievements, trends and recommendations regarding the use of JAK inhibitors in the treatment of IMIDs and also in the hyper-response phase of COVID-19 are reviewed.
Journal ArticleDOI
Rheumatoid arthritis and post-COVID-19 syndrome
TL;DR: It is thought that SARS-CoV-2 infection may be a trigger factor for new rheumatic musculoskeletal diseases, including rheumatoid arthritis or COVID-19 can unmask previously undetected RA, and arthritis in the post covid period may induce problems in differential diagnosis of rhematic diseases.
Journal ArticleDOI
Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data)
TL;DR: Preliminary data suggest that vaccination against COVID-19 in patients with IRD appears to be quite safe, and further studies are needed to investigate the safety, immunogenicity, and clinical efficacy of CO VID-19 immunization in rheumatic patients.
References
More filters
Journal ArticleDOI
Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals.
Bryant R. England,Punyasha Roul,Yangyuna Yang,Andre C. Kalil,Kaleb Michaud,Geoffrey M. Thiele,Brian C. Sauer,Joshua F. Baker,Ted R. Mikuls +8 more
TL;DR: In this article, the authors conducted a matched cohort study using national Veterans Affairs data and found that rheumatoid arthritis (RA) and its treatments are associated with an increased infection risk, but it remains unclear whether these factors impact the risk or severity of COVID-19.
Journal ArticleDOI
Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.
TL;DR: The consequence of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with concurrent co‐infections based on the publications reported to date is detrimental.
Journal ArticleDOI
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
Rebecca Hasseli,Ulf Mueller-Ladner,Bimba F. Hoyer,Andreas Krause,Hanns-Martin Lorenz,Alexander Pfeil,Jutta G Richter,Martin Schäfer,T. Schmeiser,Anja Strangfeld,Hendrik Schulze-Koops,Reinhard E. Voll,Christof Specker,Anne C. Regierer +13 more
TL;DR: In this paper, the authors describe patients with rheumatic and musculoskeletal diseases according to their COVID-19 severity and to identify risk factors for hospitalisation.
Journal ArticleDOI
Post-COVID-19 arthritis: a case report and literature review.
TL;DR: In this paper, a case of acute oligoarthritis occurring 13 days after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) severe pneumonia in a middle-aged Caucasian man was described.
Journal ArticleDOI
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
TL;DR: There are 2 faces of the immune response against SARS-CoV-2, that include a benign virus controlling immune response and a many faceted range of dysregulated multi-tissue and organ directed autoimmune responses that provides a major challenge in the management of this viral disease.